Patients 2025 predictions and AI trends for pharma executives The role of technology – particularly artificial intelligence (AI) – is top of mind for pharma executives this year (if it isn’t already).
Digital 2025: The year ahead in pharma and life sciences 2025 is going to be a year of great change. At a macro level, political and geopolitical shifts around the world will reshape relations. Regulation and deregulation may alter processes.
Digital How data science and AI will transform life sciences in 2025 Even for an industry that depends on relentless innovation to thrive, life sciences have seen remarkable advancements in recent decades.
Patients Delivering for patients and sites in 2025 As I look at 2025, and try to see what will happen in the world of clinical trials, it is important to see the progress we have made.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face